NMTC · NEUROONE MEDICAL TECHNOLOGIES Corp · Documents
$0.97
+0.11 (+12.96%)
At close · Oct 29
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$7.82M
Shares
9.11M
Volume · Oct 29
66.81K
Avg daily vol (3M)
342.04K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | NeuroOne reported preliminary fiscal 2026 revenue of approximately $10.5 million, including fourth-quarter revenue of approximately $3.8 million, up 38.4%, and a record $4.5 million purchase order, lifting open purchase orders to $5.4 million. | 2026-10-05 | — | |
| 8-K | — | 2026-08-27 | — | |
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| Interim Report | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-08-13 | — | |
| 10-Q/A | — | 2026-06-12 | 2026-03-31 | |
| 8-K | — | 2026-06-12 | — | |
| 8-K | — | 2026-05-22 | 2026-05-21 | |
| 8-K | — | 2026-05-12 | — | |
| 10-Q | — | 2026-05-12 | 2026-03-31 | |
| 8-K | — | 2026-05-04 | 2026-04-30 | |
| 8-K | — | 2026-04-30 | 2026-04-24 | |
| 8-K | — | 2026-04-14 | — | |
| 8-K | — | 2026-04-03 | — | |
| DEF 14A | — | 2026-03-09 | 2026-04-03 | |
| ARS | — | 2026-03-09 | 2025-09-30 | |
| PRE 14A | — | 2026-02-27 | 2026-04-03 | |
| 8-K | — | 2026-02-25 | — | |
| 10-Q | — | 2026-02-17 | 2025-12-31 | |
| 8-K | — | 2026-02-17 | — | |
| 10-K/A | — | 2026-01-23 | 2025-09-30 | |
| 8-K | — | 2025-12-22 | 2025-12-18 | |
| 10-K | — | 2025-12-17 | 2025-09-30 | |
| 8-K | — | 2025-12-17 | — | |
| 8-K | — | 2025-11-05 | 2025-11-04 | |
| 8-K | — | 2025-10-06 | — | |
| 8-K | — | 2025-08-18 | — | |
| 8-K | — | 2025-08-15 | — | |
| 8-K | — | 2025-08-14 | — | |
| 10-Q | — | 2025-08-14 | 2025-06-30 | |
| 8-K | — | 2025-05-13 | — | |
| 10-Q | — | 2025-05-13 | 2025-03-31 | |
| 8-K | — | 2025-05-09 | 2025-05-06 | |
| 8-K | — | 2025-04-07 | 2025-04-04 | |
| 8-K/A | — | 2025-02-20 | 2025-02-14 | |
| 8-K | — | 2025-02-14 | — | |
| 8-K | — | 2025-02-12 | — | |
| 10-Q | — | 2025-02-12 | 2024-12-31 | |
| DEFA14A | — | 2025-02-07 | — | |
| DEFA14A | — | 2025-02-05 | — | |
| 8-K | — | 2025-02-04 | 2025-02-03 | |
| ARS | — | 2025-01-21 | 2024-09-30 | |
| DEF 14A | — | 2025-01-21 | 2025-02-14 | |
| 8-K | — | 2025-01-14 | — | |
| PRE 14A | — | 2025-01-10 | — | |
| 8-K | — | 2025-01-10 | — | |
| 8-K | — | 2025-01-10 | 2025-01-08 | |
| 8-K | — | 2024-12-17 | — | |
| 10-K | — | 2024-12-17 | 2024-09-30 | |
| 8-K | — | 2024-11-08 | 2024-11-07 |
Showing 1–50 of 149 filings